TrialHepatology (Baltimore, Md.)2012

Early changes in interferon signaling define natural killer cell response and refractoriness to interferon-based therapy of hepatitis C patients.

Birgit Edlich et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.